Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preventive and therapeutic role of betaine in liver disease: A review on molecular mechanisms
Cheng Wang, Cheng Ma, Lihong Gong, et al.
European Journal of Pharmacology (2021) Vol. 912, pp. 174604-174604
Closed Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases
Jing Zhen, Zhou Zhou, Meng He, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 88
High Fischer ratio oligopeptides from hard-shelled mussel: Preparation and hepatoprotective effect against acetaminophen-induced liver injury in mice
Shuo-Lei Zheng, Yue-Zheng Wang, Yu‐Qin Zhao, et al.
Food Bioscience (2023) Vol. 53, pp. 102638-102638
Closed Access | Times Cited: 51
Betaine as a Functional Ingredient: Metabolism, Health-Promoting Attributes, Food Sources, Applications and Analysis Methods
Dejan Dobrijević, Kristian Pastor, Nataša Nastić, et al.
Molecules (2023) Vol. 28, Iss. 12, pp. 4824-4824
Open Access | Times Cited: 51
Natural products in atherosclerosis therapy by targeting PPARs: a review focusing on lipid metabolism and inflammation
Yan Zhang, Xueying Zhang, Shan-Rui Shi, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 11
Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies
Xin Ding, Xu He, Bulang Tang, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 10
Epigenetic biomarkers for disease susceptibility and preventative medicine
Michael K. Skinner
Cell Metabolism (2024) Vol. 36, Iss. 2, pp. 263-277
Closed Access | Times Cited: 6
Altered metabolome and microbiome associated with compromised intestinal barrier induced hepatic lipid metabolic disorder in mice after subacute and subchronic ozone exposure
Wenjia Lu, Chonggui Jiang, Yajie Chen, et al.
Environment International (2024) Vol. 185, pp. 108559-108559
Open Access | Times Cited: 6
The anti-diabetic potential of betaine. Mechanisms of action in rodent models of type 2 diabetes
Katarzyna Szkudelska, Tomasz Szkudelski
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 112946-112946
Open Access | Times Cited: 25
Betaine Mitigates Amyloid-β-Associated Neuroinflammation by Suppressing the NLRP3 and NF-κB Signaling Pathways in Microglial Cells
Yue Zhang, Jianping Jia
Journal of Alzheimer s Disease (2023) Vol. 94, Iss. s1, pp. S9-S19
Open Access | Times Cited: 14
Betaine alleviates nonalcoholic fatty liver disease (NAFLD) via a manner involving BHMT/FTO/m6A/ PGC1α signaling
Jiaqi Liu, Yuxi Liu, Yushi Chen, et al.
The Journal of Nutritional Biochemistry (2024) Vol. 134, pp. 109738-109738
Closed Access | Times Cited: 4
Insights into the Metabolite Differentiation Mechanism Between Chinese Dry-Cured Fatty Ham and Lean Ham Through UPLC-MS/MS-Based Untargeted Metabolomics
Ruoyu Xie, Xiaoli Wu, Jun Hu, et al.
Foods (2025) Vol. 14, Iss. 3, pp. 505-505
Open Access
Integrated metabolomics and transcriptomics reveal the potential of hydroxy-alpha-sanshool in alleviating insulin resistance
Yuping Zhu, Pan Yang, Tingyuan Ren, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Low Glycemic Index Biscuits Enriched with Beetroot Powder as a Source of Betaine and Mineral Nutrients
Jasmina Mitrevski, Nebojša Đ. Pantelić, Jovanka Laličić-Petronijević, et al.
Foods (2025) Vol. 14, Iss. 5, pp. 814-814
Open Access
Role of autophagy in betaine-promoted hepatoprotection against non-alcoholic fatty liver disease in mice
Jinuk Seo, Do-Young Kwon, Sou Hyun Kim, et al.
Current Research in Food Science (2023) Vol. 8, pp. 100663-100663
Open Access | Times Cited: 10
Folate Deficiency and/or the Genetic Variant Mthfr677C >T Can Drive Hepatic Fibrosis or Steatosis in Mice, in a Sex‐Specific Manner
Daniel Leclerc, Karen E. Christensen, Alaina M. Reagan, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 5
Open Access | Times Cited: 3
Effect of three oral pathogens on the TMA-TMAO metabolic pathway
Xixuan Wang, Liyuan Chen, Teng Ye, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 3
PPARα in the Epigenetic Driver Seat of NAFLD: New Therapeutic Opportunities for Epigenetic Drugs?
Claudia Theys, Dorien Lauwers, Claudina Pérez-Novo, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3041-3041
Open Access | Times Cited: 14
The pharmacological role of Ginsenoside Rg3 in liver diseases: A review on molecular mechanisms
Wenhong Wang, Ke Li, Weihua Xiao
Journal of Ginseng Research (2023) Vol. 48, Iss. 2, pp. 129-139
Open Access | Times Cited: 8
Untargeted metabonomics and TLR4/ NF-κB signaling pathway analysis reveals potential mechanism of action of Dendrobium huoshanense polysaccharide in nonalcoholic fatty liver disease
Guanghui Deng, Chenchen Zhao, Xiao Cai, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Unlocking Cholesterol Metabolism in Metabolic-Associated Steatotic Liver Disease: Molecular Targets and Natural Product Interventions
X. Li, Meng Li
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1073-1073
Open Access | Times Cited: 2
An in vivo and in silico probing of the protective potential of betaine against sodium fluoride-induced neurotoxicity
Solomon E. Owumi, Bayode J. Oluwawibe, Joseph Chimezie, et al.
BMC Pharmacology and Toxicology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Research Progress of Chinese Medicine in Treating Chronic Liver Disease by Regulating Autophagy
Shihao Zheng, Chengyuan Xue, Tianyu Xue, et al.
The American Journal of Chinese Medicine (2024), pp. 1-25
Closed Access | Times Cited: 2
Aberrant Mesenteric Adipose Extracellular Matrix Remodelling is Involved in Adipocyte Dysfunction in Crohn’s Disease: The Role of TLR-4-mediated Macrophages
Lugen Zuo, Jing Li, Xiaofeng Zhang, et al.
Journal of Crohn s and Colitis (2022) Vol. 16, Iss. 11, pp. 1762-1776
Closed Access | Times Cited: 8
RNA-binding proteins in metabolic-associated fatty liver disease (MAFLD): From mechanism to therapy
Jiawei Xu, Xingyu Liu, WU Shu-qin, et al.
BioScience Trends (2023) Vol. 17, Iss. 1, pp. 21-37
Open Access | Times Cited: 4
Metabolomics reveals that chronic restraint stress alleviates carbon tetrachloride-induced hepatic fibrosis through the INSR/PI3K/AKT/AMPK pathway
Shanshan Zhang, Binjie Liu, Lan Huang, et al.
Journal of Molecular Medicine (2023) Vol. 102, Iss. 1, pp. 113-128
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top